![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MIS18BP1 |
Gene summary for MIS18BP1 |
![]() |
Gene information | Species | Human | Gene symbol | MIS18BP1 | Gene ID | 55320 |
Gene name | MIS18 binding protein 1 | |
Gene Alias | C14orf106 | |
Cytomap | 14q21.2 | |
Gene Type | protein-coding | GO ID | GO:0007049 | UniProtAcc | Q6P0N0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55320 | MIS18BP1 | LZE2T | Human | Esophagus | ESCC | 8.76e-10 | 7.54e-01 | 0.082 |
55320 | MIS18BP1 | LZE4T | Human | Esophagus | ESCC | 1.51e-13 | 3.61e-01 | 0.0811 |
55320 | MIS18BP1 | LZE5T | Human | Esophagus | ESCC | 4.41e-05 | 5.67e-01 | 0.0514 |
55320 | MIS18BP1 | LZE7T | Human | Esophagus | ESCC | 1.92e-06 | 3.68e-01 | 0.0667 |
55320 | MIS18BP1 | LZE8T | Human | Esophagus | ESCC | 7.49e-05 | 1.27e-01 | 0.067 |
55320 | MIS18BP1 | LZE20T | Human | Esophagus | ESCC | 1.23e-03 | 2.89e-01 | 0.0662 |
55320 | MIS18BP1 | LZE24T | Human | Esophagus | ESCC | 9.14e-16 | 3.64e-01 | 0.0596 |
55320 | MIS18BP1 | LZE22D3 | Human | Esophagus | HGIN | 2.44e-02 | 3.78e-01 | 0.0653 |
55320 | MIS18BP1 | LZE21T | Human | Esophagus | ESCC | 4.29e-03 | 2.81e-01 | 0.0655 |
55320 | MIS18BP1 | LZE6T | Human | Esophagus | ESCC | 2.07e-02 | 1.25e-01 | 0.0845 |
55320 | MIS18BP1 | P1T-E | Human | Esophagus | ESCC | 2.51e-13 | 5.93e-01 | 0.0875 |
55320 | MIS18BP1 | P2T-E | Human | Esophagus | ESCC | 1.57e-30 | 7.38e-01 | 0.1177 |
55320 | MIS18BP1 | P4T-E | Human | Esophagus | ESCC | 1.39e-23 | 7.23e-01 | 0.1323 |
55320 | MIS18BP1 | P5T-E | Human | Esophagus | ESCC | 1.14e-39 | 8.22e-01 | 0.1327 |
55320 | MIS18BP1 | P8T-E | Human | Esophagus | ESCC | 5.08e-34 | 6.38e-01 | 0.0889 |
55320 | MIS18BP1 | P9T-E | Human | Esophagus | ESCC | 6.22e-15 | 4.48e-01 | 0.1131 |
55320 | MIS18BP1 | P10T-E | Human | Esophagus | ESCC | 3.83e-38 | 7.36e-01 | 0.116 |
55320 | MIS18BP1 | P11T-E | Human | Esophagus | ESCC | 2.73e-07 | 3.00e-01 | 0.1426 |
55320 | MIS18BP1 | P12T-E | Human | Esophagus | ESCC | 2.50e-23 | 5.09e-01 | 0.1122 |
55320 | MIS18BP1 | P15T-E | Human | Esophagus | ESCC | 5.24e-19 | 5.70e-01 | 0.1149 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MIS18BP1 | SNV | Missense_Mutation | c.2194N>C | p.Glu732Gln | p.E732Q | Q6P0N0 | protein_coding | deleterious(0.03) | benign(0.024) | TCGA-AC-A5XS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | femara | SD | |
MIS18BP1 | SNV | Missense_Mutation | novel | c.609N>T | p.Lys203Asn | p.K203N | Q6P0N0 | protein_coding | tolerated(0.07) | benign(0.031) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MIS18BP1 | SNV | Missense_Mutation | c.862N>G | p.Leu288Val | p.L288V | Q6P0N0 | protein_coding | tolerated(0.5) | benign(0.024) | TCGA-AN-A0AT-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MIS18BP1 | SNV | Missense_Mutation | novel | c.917G>A | p.Ser306Asn | p.S306N | Q6P0N0 | protein_coding | tolerated(0.43) | benign(0.021) | TCGA-AR-A0TU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Doxorubicin | SD |
MIS18BP1 | SNV | Missense_Mutation | novel | c.1754T>G | p.Ile585Ser | p.I585S | Q6P0N0 | protein_coding | tolerated(0.29) | benign(0.017) | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MIS18BP1 | SNV | Missense_Mutation | c.2702G>T | p.Gly901Val | p.G901V | Q6P0N0 | protein_coding | deleterious(0) | probably_damaging(0.974) | TCGA-BH-A0DQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
MIS18BP1 | SNV | Missense_Mutation | novel | c.3161G>T | p.Cys1054Phe | p.C1054F | Q6P0N0 | protein_coding | tolerated(0.18) | benign(0.367) | TCGA-BH-A0W7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR |
MIS18BP1 | SNV | Missense_Mutation | c.2581N>C | p.Asp861His | p.D861H | Q6P0N0 | protein_coding | tolerated(0.06) | benign(0.201) | TCGA-C8-A8HQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MIS18BP1 | SNV | Missense_Mutation | c.2579C>G | p.Ser860Cys | p.S860C | Q6P0N0 | protein_coding | deleterious(0.04) | benign(0.01) | TCGA-D8-A1J8-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | nolvadex | SD | |
MIS18BP1 | SNV | Missense_Mutation | c.29N>C | p.Arg10Thr | p.R10T | Q6P0N0 | protein_coding | tolerated(0.11) | benign(0.043) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |